“Higher Risk of Acute Kidney Injury (AKI) with Vancomycin and Piperacillin Tazobactam (VAN-TZP) Compared to Vancomycin and Ceftolozane Tazobactam (VAN-C/T), US Multicenter Study Finds”

2023-05-25 15:05:09

The results of a US multicenter study show that the risk of acute kidney injury (AKI) is significantly higher in patients treated with vancomycin in combination with piperacillin tazobactam (VAN-TZP) compared to vancomycin in combination with ceftolozane tazobactam (VAN-C /T), even after adjusting for independent predictors for AKI.

More information is only accessible to subscribers who have prescribing authority.

Login

NB: To see all information you need an account to log in. Are you already logged in? Then you do not have sufficient rights to view this information. Do you want to adjust your account? Then click here